The European Food Safety Authority released a statement in July 2019 which concluded that the approval criteria for chlorpyrifos which apply to human health are not met. Their literature review concluded that there is no evidence for reproductive toxicity in rats, but that chlorpyrifos is potentially genotoxic. The report stated that chlorpyrifos is clearly a potent Acetylcholinesterase inhibitor, that it can be absorbed by ingestion, inhalation, and through the skin, and that epidemiological evidence supports the hypothesis that it is a human developmental neurotoxin that can cause early cognitive and behavioral deficits through prenatal exposure.